
VANCOUVER, British Columbia, Oct. 23, 2026 — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) announced that it has granted an aggregate of 3,143 stock options, exercisable at $0.70 per share for a term of three years, and 239,000 restricted share units (RSUs), with terms ranging from three to five years.
The awards have been granted to an officer of the Company and to consultants and employees of its subsidiary under the Company’s share compensation plans. All stock options and RSUs are subject to vesting conditions over a period of up to one year. The securities are also subject to a hold period of four months and one day, in accordance with applicable securities laws and Canadian Securities Exchange policies.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. provides physician-developed, AI-powered solutions designed to improve access to quality healthcare throughout the patient journey. A key component of the Company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision-support system developed with contributions from hundreds of physicians worldwide.
The Company also operates Rocket Doctor Inc., which provides an AI-powered digital health platform and marketplace. The platform has helped more than 350 physicians provide over 800,000 patient visits. Its proprietary software and systems enable physicians to independently establish and manage virtual or hybrid in-person practices, improving operational efficiency, supporting physician autonomy, and expanding patient access to care.
By reducing administrative workloads and supporting greater consistency in care delivery, the Company’s technology is designed to provide more time for meaningful interactions between physicians and patients. Rocket Doctor AI is focused on improving access to healthcare in underserved, rural, and remote communities across Canada, where access to family physicians can be limited. The Company also supports patients covered by Medicaid and Medicare in the United States.
Through the use of advanced AI, large language models, and connected medical devices, Rocket Doctor AI aims to make healthcare delivery more scalable, accessible, and patient-centered.
For more information about Rocket Doctor AI Inc. and its products and services, visit www.rocketdoctor.ai or contact [email protected].
Company Contacts
Dr. Essam Hamza
CEO, Rocket Doctor AI
[email protected]
Dr. Bill Cherniak
CEO, Rocket Doctor Inc.
[email protected]
Media Inquiries
Email: [email protected]
Phone: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will,” “may,” “should,” “anticipate,” “expects,” and similar expressions.
All statements in this release other than statements of historical fact, including statements regarding the granting of stock options and restricted share units to consultants, the terms and vesting conditions of these awards, and the Company’s future plans and objectives, are forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be accurate. Actual results and future events may differ materially from those anticipated in these statements. Important factors that could cause actual results to differ materially from the Company’s expectations include the possibility that the stock options or restricted share units may not vest on the anticipated terms, risks associated with the Company’s share compensation plan, and other risks described in the Company’s filings with securities regulators from time to time.
Readers are cautioned that assumptions used in preparing forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted due to numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control.
Readers should not place undue reliance on forward-looking information. Although management considers such information reasonable at the time of preparation, it may prove to be incorrect, and actual results may differ materially from those anticipated. The forward-looking statements in this release are expressly qualified by this cautionary statement.
All forward-looking statements contained in this news release are made as of the date of this release. Rocket Doctor AI Inc. undertakes to update or revise these statements publicly only when expressly required under applicable Canadian securities laws.

